by Jordana Choucair | Nov 2, 2021 | Life Sciences
Eli Lilly and Co. announced that the U.S. government bought 614,000 additional doses of its COVID-19 antibody therapy for $1.29 billion. As part of the agreement, Lilly will supply a minimum of 400,000 doses of bamlanivimab with etesevimab no later than December 31,...
by Jordana Choucair | Nov 2, 2021 | Life Sciences
Pfizer said its COVID-19 vaccine brought in $13 billion in sales in the third quarter and boosted its year-end forecast to $36 billion due to global deals for booster shots and broader eligibility for the vaccine. The company said it plans to deliver 2.3 billion doses...
by Jordana Choucair | Nov 2, 2021 | Life Sciences
Jeffrey Zients, the White House’s COVID-19 response coordinator, said the federal government has already begun shipping 15 million doses of Pfizer’s COVID-19 vaccine for younger children. Zients said pediatric vaccine rollout will begin “running at full...
by Jordana Choucair | Nov 1, 2021 | Life Sciences
The FDA issued emergency use authorization on Friday for Pfizer’s Covid-19 vaccine for children 5 to 11 years old. The agency authorized a two-dose series of the vaccine, but with just one-third of the active ingredient compared to the adult dosage. The...
by Jordana Choucair | Oct 26, 2021 | Life Sciences
Moderna released trial results for its COVID-19 vaccine for children aged 6 to 11, saying it provides a “robust” immune response after two doses. The company said that two 50-microgram doses of the vaccine, half the dosage given to adults, produced...
by Jordana Choucair | Oct 25, 2021 | Life Sciences
Anthony Fauci told ABC News that if regulators authorize COVID-19 vaccines for children between the ages of 5 and 11, shorts could be available within the first two weeks of November. A key FDA advisory committee plans to meet Tuesday to discuss shots for that age...
Recent Comments